Research News and Research

RSS

CTTC's Calmare therapy effective against pain associated with chemotherapy-induced peripheral neuropathy

Competitive Technologies, Inc. announced today the publication of the detailed results from a study that shows the successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy (CIPN) using CTTC's Calmare® Pain Therapy Treatment

9 Sep 2010

Scientists discover natural mechanism to discard amyloid protein

Chemists at the University of California, San Diego, have identified how a protein that accumulates in the brains of people with Alzheimer's disease interferes with the ability of cells to get rid of debris. They also found a natural mechanism by which this protein, amyloid beta, itself may be discarded.

9 Sep 2010

NIH awards second $8 million grant for research into health effects of botanical estrogens

An ongoing research initiative into the health effects of botanical estrogens will get an $8 million boost from the National Institutes of Health.

9 Sep 2010

Team of scientists issues HIV vaccine strategy

The Council of the Global HIV Vaccine Enterprise on Tuesday released a new strategy for HIV vaccine research, which marked "the culmination of an 18-month effort that included the input of 400 scientists worldwide," VOA News reports (DeCapua, 9/7).

9 Sep 2010

Hemispherx Biopharma to present clinical data on XMRV retrovirus at International Workshop

Hemispherx Biopharma, Inc. will present new clinical data on the possible inter-relationships of XMRV positivity/chronic fatigue syndrome/Ampligen responsiveness at the 1st International Workshop on XMRV being held at the National Institutes of Health in Bethesda, MD, on September 7 and 8, 2010.

9 Sep 2010

States continue to wrestle with federal funding issues, budget shortfalls

The Fiscal Times: "Nationally, the number of Medicaid beneficiaries has risen by 8 percent a year since 2008, and 44 states have reported that they will exceed their enrollment and spending growth projections this year, the Kaiser Commission on Medicaid and the Uninsured reported. A dozen other states, including Arizona, Utah, Wisconsin and Maryland, have experienced double-digit annual enrollment increases."

9 Sep 2010

ReVision Optics completes enrollment, initial follow up in PresbyLens Phase I clinical trial for presbyopia

ReVision Optics, a leading company in the research, development and manufacture of implantable medical devices designed to assist patients that need reading glasses, announced today that it has completed enrollment and initial follow up in Phase I of its US clinical trial and has filed for expansion. The clinical trial is for the study of the PresbyLens, recently renamed Vue+, for the improvement of near vision in patients with presbyopia, the age-related loss of near vision.

9 Sep 2010

Indiana State Legislators holds hearing to improve methamphetamine production

Today, the Indiana State Legislature's Criminal Law and Sentencing Policy Study Committee is holding a hearing on how the state can improve its policies for preventing the illegal diversion of pseudoephedrine (PSE) a key ingredient in leading cold and allergy medicines for methamphetamine production.

9 Sep 2010

Federal judge refuses to lift order blocking federal funding for stem cell research

The Associated Press: "A federal judge on Tuesday refused to lift his order blocking federal funding for some stem cell research, saying that a 'parade of horribles' predicted by federal officials would not happen. Medical researchers value stem cells because they are master cells that can turn into any tissue of the body.

9 Sep 2010

AERI merges with AHEADD to support communities impacted by Autism Spectrum Disorder

The Autism Education and Research Institute (AERI), an organization committed to providing consultative services that incorporates innovative current research in the field of autism, announces their merging with Achieving in Higher Education with Autism / Developmental Disabilities (AHEADD) in order to support consumers, families, schools, and their surrounding communities who are impacted by Autism Spectrum Disorders (ASD).

9 Sep 2010

High testosterone levels in CEOs linked to higher rate of dropped deals in negotiating M&As

High testosterone levels in CEOs negotiating mergers and acquisitions are linked to a higher rate of dropped deals and an increase in hostile takeover attempts, according to a new study in the current issue of Management Science, a journal of the Institute for Operations Research and the Management Sciences (INFORMS-).

9 Sep 2010

Irregular body weight increases mortality risk in women with colon cancer: Study

Postmenopausal women diagnosed with colon cancer may be at increased risk of death if they fail to maintain a healthy body weight before cancer diagnosis, according to a study published in the September issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

9 Sep 2010

Researchers synthesize new compounds to reduce A-beta 42 peptide in Alzheimer's disease

A team of scientists, led by University of California, San Diego School of Medicine researchers, has synthesized hundreds of new compounds with the potential of reducing the production of the A-beta 42 peptide, a primary component of Alzheimer's disease (AD).

9 Sep 2010

Insurers raise rates, cancel plans in response to overhaul

The Wall Street Journal: "Aetna Inc., some BlueCross BlueShield plans and other smaller carriers have asked for premium increases of between 1% and 9% to pay for extra benefits required under the law, according to filings with state regulators." The requests undermine "Democrats' efforts to trumpet their signature achievement before the midterm elections."

9 Sep 2010

'Cloud computing improves' speed of analyzing RNA sequencing data

Researchers at the Johns Hopkins Bloomberg School of Public Health have developed new software that greatly improves the speed at which scientists can analyze RNA sequencing data. RNA sequencing is used to compare differences in gene expression to identify those genes that switched on or off when, for instance, a particular disease is present.

9 Sep 2010

Researchers report massage improves body’s immune response

Researchers in Cedars-Sinai's Department of Psychiatry and Behavioral Neurosciences have reported people who undergo massage experience measureable changes in their body's immune and endocrine response.

9 Sep 2010

Cylene Pharmaceuticals to report recent developments of CX-4945 inhibitor at CK2 International Conference

Cylene Pharmaceuticals, Inc. will report recent developments with its first-in-class, oral CK2 inhibitor CX-4945, at the 6th International Conference on Protein Kinase CK2, to be held on September 7-10 in Cologne, Germany, the company announced today.

9 Sep 2010

Health reform myths debunked

The Associated Press examines political ads on health reform. "With the country sharply divided over the sweeping new insurance law, Republicans and their allies are taking to the airwaves to attack it as elections near, often resorting to exaggeration and omissions to make their points."

9 Sep 2010

Helicos accuses PacBio of patent infringement, files lawsuit

Helicos BioSciences Corporation announced today that it has filed a lawsuit against Pacific Biosciences of California, Inc. for patent infringement. The lawsuit, filed in the United States District Court for the District of Delaware, accuses PacBio of infringing four patents and seeks injunctive relief and monetary damages.

9 Sep 2010

Ohio State University receives five-year grant to improve drug therapy using gene profiles

The National Institute of General Medical Sciences has awarded a $9.1 million, five-year grant to The Ohio State University for a study titled "Expression Genetics in Drug Therapy." The goal of the research is to enhance drug response rates and reduce the number of adverse drug reactions among patients taking medication.

9 Sep 2010

Research News and Research

CTTC's Calmare therapy effective against pain associated with chemotherapy-induced peripheral neuropathy

Scientists discover natural mechanism to discard amyloid protein

NIH awards second $8 million grant for research into health effects of botanical estrogens

Team of scientists issues HIV vaccine strategy

Hemispherx Biopharma to present clinical data on XMRV retrovirus at International Workshop

States continue to wrestle with federal funding issues, budget shortfalls

ReVision Optics completes enrollment, initial follow up in PresbyLens Phase I clinical trial for presbyopia

Indiana State Legislators holds hearing to improve methamphetamine production

Federal judge refuses to lift order blocking federal funding for stem cell research

AERI merges with AHEADD to support communities impacted by Autism Spectrum Disorder

High testosterone levels in CEOs linked to higher rate of dropped deals in negotiating M&As

Irregular body weight increases mortality risk in women with colon cancer: Study

Researchers synthesize new compounds to reduce A-beta 42 peptide in Alzheimer's disease

Insurers raise rates, cancel plans in response to overhaul

'Cloud computing improves' speed of analyzing RNA sequencing data

Researchers report massage improves body’s immune response

Cylene Pharmaceuticals to report recent developments of CX-4945 inhibitor at CK2 International Conference

Health reform myths debunked

Helicos accuses PacBio of patent infringement, files lawsuit

Ohio State University receives five-year grant to improve drug therapy using gene profiles

A guide to advancing biotherapeutic research eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence